Doctors at the Mayo Clinic say they're optimistic about a new weapon in the fight against B-Cell, Non-Hodgkin's Lymphoma. They say the drug, Zevalin is able to zero in on tumors without affecting the whole body like chemotherapy. Experts studied 143 patients who failed to respond to standard treatment. They found that 80% of patients who took Zevalin showed a reduction in tumor size. 30% went into complete remission with no evidence of cancer. B-Cell Non-Hodgkin's Lymphoma affects 56,000 people each year.
If you want to enjoy a good life when you're older, then enjoy plenty of friends, family, and fun now. That's the word of a new study in the Journal, Psychosomatic Medicine. Experts found that positive experiences accumulated over a lifetime helped to counteract the effects of aging. Men and women with good childhoods and good marriages had lower blood pressure, cholesterol levels, blood sugar metabolism, and hormonal levels.
A discreet drug patch may soon make treatment easier for kids diagnosed with attention deficit hyperactivity disorder. The Methypatch continuously delivers the active ingredient in Ritalin right through the skin. It eliminates the need for kids to take medication at school. It also allows kids to receive treatment without the fear of ridicule or teasing. The Methypatch is now in phase three clinical trials. If it's approved by the FDA, it could be available sometime next year.